159 related articles for article (PubMed ID: 19046788)
1. BCCIP as a prognostic marker for radiotherapy of laryngeal cancer.
Rewari A; Lu H; Parikh R; Yang Q; Shen Z; Haffty BG
Radiother Oncol; 2009 Feb; 90(2):183-8. PubMed ID: 19046788
[TBL] [Abstract][Full Text] [Related]
2. [Effect of p53 expression in the primary lesion and the surgical margin on the postoperative radiotherapy for laryngeal squamous carcinoma].
Xia LP; Zeng ZY; Guo ZM; Rao HL; Zeng J; Xu GP; Hou JH
Zhonghua Zhong Liu Za Zhi; 2003 Nov; 25(6):558-61. PubMed ID: 14690561
[TBL] [Abstract][Full Text] [Related]
3. Is p53 an independent prognostic factor in patients with laryngeal carcinoma?
Narayana A; Vaughan AT; Gunaratne S; Kathuria S; Walter SA; Reddy SP
Cancer; 1998 Jan; 82(2):286-91. PubMed ID: 9445184
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of p53 protein does not predict local-regional control or survival in patients with early-stage squamous cell carcinoma of the glottic larynx treated with radiotherapy.
Pai HH; Rochon L; Clark B; Black M; Shenouda G
Int J Radiat Oncol Biol Phys; 1998 Apr; 41(1):37-42. PubMed ID: 9588915
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of clinical factors and p53 expression in patients with glottic carcinoma treated with radiation therapy.
Kokoska MS; Piccirillo JF; el-Mofty SK; Emami B; Haughey BH; Schoinick SB
Cancer; 1996 Oct; 78(8):1693-700. PubMed ID: 8859182
[TBL] [Abstract][Full Text] [Related]
6. [Relation between epidermal growth factor receptor (EGFR) and p53 expression and radiocurability of laryngeal squamous cell cancer].
Dupla D; Fraczek M; Woźniak Z; Krecicki T
Otolaryngol Pol; 2009; 63(3):249-55. PubMed ID: 19886531
[TBL] [Abstract][Full Text] [Related]
7. p53 protein expression in tumours from head and neck subsites, larynx and hypopharynx, and differences in relationship to survival.
Rowley H; Roland NJ; Helliwell TR; Caslin A; Kinsella AR; Jones AS
Clin Otolaryngol Allied Sci; 1998 Feb; 23(1):57-62. PubMed ID: 9563667
[TBL] [Abstract][Full Text] [Related]
8. Correlation of tumor markers p53, bcl-2, CD34, CD44H, CD44v6, and Ki-67 with survival and metastasis in laryngeal squamous cell carcinoma.
Spafford MF; Koeppe J; Pan Z; Archer PG; Meyers AD; Franklin WA
Arch Otolaryngol Head Neck Surg; 1996 Jun; 122(6):627-32. PubMed ID: 8639294
[TBL] [Abstract][Full Text] [Related]
9. MIB-1 and p53 expression in radiotherapy-resistant T1aN0M0 glottic squamous cell carcinoma.
Motamed M; Banerjee AR; Bradley PJ; Powe D
Clin Otolaryngol Allied Sci; 2001 Jun; 26(3):227-30. PubMed ID: 11437847
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylation of gH2AX as a novel prognostic biomarker for laryngoesophageal dysfunction-free survival.
de Miguel-Luken MJ; Chaves-Conde M; Quintana B; Menoyo A; Tirado I; de Miguel-Luken V; Pachón J; Chinchón D; Suarez V; Carnero A
Oncotarget; 2016 May; 7(22):31723-37. PubMed ID: 27166270
[TBL] [Abstract][Full Text] [Related]
11. Expression of EpCAM and prognosis in early-stage glottic cancer treated by radiotherapy.
Murakami N; Mori T; Yoshimoto S; Ito Y; Kobayashi K; Ken H; Kitaguchi M; Sekii S; Takahashi K; Yoshio K; Inaba K; Morota M; Sumi M; Itami J
Laryngoscope; 2014 Nov; 124(11):E431-6. PubMed ID: 25043563
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of G1 cell-cycle inhibitors in early laryngeal cancer.
Korkmaz H; Du W; Yoo GH; Enamorado II; Lin HS; Adsay V; Kewson D; Ensley JF; Shibuya TY; Jacobs JR; Kim H
Am J Otolaryngol; 2005; 26(2):77-82. PubMed ID: 15742257
[TBL] [Abstract][Full Text] [Related]
13. Fuse binding protein antagonizes the transcription activity of tumor suppressor protein p53.
Dixit U; Liu Z; Pandey AK; Kothari R; Pandey VN
BMC Cancer; 2014 Dec; 14():925. PubMed ID: 25487856
[TBL] [Abstract][Full Text] [Related]
14. Tissue microarray analysis reveals prognostic significance of COX-2 expression for local relapse in T1-2N0 larynx cancer treated with primary radiation therapy.
Cho EI; Kowalski DP; Sasaki CT; Haffty BG
Laryngoscope; 2004 Nov; 114(11):2001-8. PubMed ID: 15510031
[TBL] [Abstract][Full Text] [Related]
15. Roles of BCCIP deficiency in mammary tumorigenesis.
Droz-Rosario R; Lu H; Liu J; Liu NA; Ganesan S; Xia B; Haffty BG; Shen Z
Breast Cancer Res; 2017 Oct; 19(1):115. PubMed ID: 29047390
[TBL] [Abstract][Full Text] [Related]
16. Changes in expression of p53, proliferating cell nuclear antigen and bcl-2 in recurrent laryngeal cancer after radiotherapy.
Lee BJ; Wang SG; Roh HJ; Goh EK; Chon KM; Park DY
J Laryngol Otol; 2006 Jul; 120(7):579-82. PubMed ID: 16672091
[TBL] [Abstract][Full Text] [Related]
17. P53 overexpression is associated with bulky tumor and poor local control in T1 glottic cancer.
Narayana A; Vaughan AT; Kathuria S; Fisher SG; Walter SA; Reddy SP
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):21-6. PubMed ID: 10656367
[TBL] [Abstract][Full Text] [Related]
18. Nuclear DNA content, proliferating-cell nuclear antigen (PCNA) and p53 immunostaining in predicting progression of laryngeal cancer in situ lesions.
Munck-Wikland E; Edström S; Jungmark E; Kuylenstierna R; Lindholm J; Auer G
Int J Cancer; 1994 Jan; 56(1):95-9. PubMed ID: 7903288
[TBL] [Abstract][Full Text] [Related]
19. High Expression of BCCIP β Can Promote Proliferation of Esophageal Squamous Cell Carcinoma.
Chen L; Ni S; Li M; Shen C; Lin Z; Ouyang Y; Xia F; Liang L; Jiang W; Ni R; Zhang J
Dig Dis Sci; 2017 Feb; 62(2):387-395. PubMed ID: 27995408
[TBL] [Abstract][Full Text] [Related]
20. YY1/BCCIP Coordinately Regulates P53-Responsive Element (p53RE)-Mediated Transactivation of p21
Sui Y; Wu T; Li F; Wang F; Cai Y; Jin J
Int J Mol Sci; 2019 Apr; 20(9):. PubMed ID: 31035388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
